SCHEMBL246957

SCHEMBL246957

[CH2]CCCC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL245799 0.90
SCHEMBL153092 0.87
SCHEMBL8728916 0.87
SCHEMBL1394302 0.87
SCHEMBL25411901 0.87
SCHEMBL25413484 0.87
SCHEMBL25412754 0.87
SCHEMBL25414366 0.87
SCHEMBL472208 0.87
SCHEMBL864037 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2781 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115260186-B VMAT2 inhibitor and preparation method and application thereof 山东绿叶制药有限公司 2024-05-28 CN claimed
CN-112689509-B Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof 梅特恩生物科学有限公司 2024-03-29 CN claimed
WO-2024064178-A1 HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLINE VMAT2 INHIBITORS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2024-03-28 WO claimed
CN-117700635-A Dispersing thickener, preparation method and application thereof 浙江震东新材料有限公司 2024-03-15 CN claimed
US-20230391725-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY EVOTEC INTERNATIONAL GMBH (DE) 2023-12-07 US claimed
CN-117062815-A VMAT2 inhibitors and methods of use 纽罗克里生物科学有限公司 2023-11-14 CN claimed
WO-2023178065-A2 LIPID COMPOUNDS AND LIPID NANOPARTICLES BROADPHARM INC. (US) 2023-09-21 WO claimed
EP-4232153-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY Evotec International GmbH (DE) 2023-08-30 EP claimed
EP-3880676-B1 2,3-DIHYDRO-1H-PYRROLO[3,4-C]PYRIDIN-1-ONE DERIVATIVES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER PFIZER (US) 2023-08-02 EP claimed
EP-4168409-A1 VMAT2 INHIBITORS AND METHODS OF USE Neurocrine Biosciences, Inc. (US) 2023-04-26 EP claimed
EP-0114172-B1 ANTI-INFLAMMATORY COMPOSITION MERCK & CO. INC. (US) 1987-04-29 EP claimed
EP-0163416-A2 Phenol derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-12-04 EP claimed
EP-0114172-A1 Anti-inflammatory composition MERCK & CO. INC. (US) 1984-08-01 EP claimed
US-4389525-A Process for the resolution of some interphenylene 9-thia-11-oxo-12-azaprostanoic acids MERCK & CO., INC. (US) 1983-06-21 US claimed
US-4379792-A Anti-inflammatory composition MERCK & CO., INC. (US) 1983-04-12 US claimed
EP-0001900-B1 9-THIA-12-AZAPROSTANOIC ACID DERIVATIVES AND COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1982-04-07 EP claimed
US-4225609-A Interphenylene 9-thia-11-oxo-12-aza-prostanoic acids MERCK & CO., INC. (US) 1980-09-30 US claimed
EP-0001900-A1 9-Thia-12-azaprostanoic acid derivatives and compositions containing them MERCK & CO. INC. (US) 1979-05-16 EP claimed
US-4117014-A PROSTAGLANDIN DERIVATIVES ABBOTT LABORATORIES (US) 1978-09-26 US claimed
US-4055597-A RENAL VASODILATORS MERCK & CO., INC. (US) 1977-10-25 US claimed